JW (Cayman) Therapeutics Co. Ltd (2126.HK)
HKD 1.3
(0.0%)
HKD 1.3
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 318.79 Million CNY | 14.21% |
| 2022 | 279.12 Million CNY | 89.84% |
| 2021 | 147.03 Million CNY | 18.97% |
| 2020 | 123.59 Million CNY | 58.89% |
| 2019 | 77.78 Million CNY | 32.53% |
| 2018 | 58.69 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 333.6 Million CNY | 0.0% |
| 2023 Q2 | 421.42 Million CNY | 0.0% |
| 2023 Q4 | 318.79 Million CNY | 0.0% |
| 2023 FY | 318.79 Million CNY | 14.21% |
| 2022 FY | 279.12 Million CNY | 89.84% |
| 2022 Q4 | 313.38 Million CNY | 0.0% |
| 2022 Q2 | 175.85 Million CNY | 0.0% |
| 2021 Q4 | 179.86 Million CNY | 0.0% |
| 2021 Q2 | 151.51 Million CNY | 0.0% |
| 2021 FY | 147.03 Million CNY | 18.97% |
| 2020 FY | 123.59 Million CNY | 58.89% |
| 2020 Q4 | 146.53 Million CNY | 0.0% |
| 2020 Q2 | 3.02 Billion CNY | 0.0% |
| 2019 Q4 | 1.67 Billion CNY | 0.0% |
| 2019 FY | 77.78 Million CNY | 32.53% |
| 2019 Q2 | - HKD | 0.0% |
| 2018 FY | 58.69 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 52.86 Million HKD | -503.013% |
| CK Life Sciences Int'l., (Holdings) Inc. | 5.93 Billion HKD | 94.625% |